In innovation processes, it is well established that knowledge spillovers can exist, whereby investments in knowledge creation by one party produces external benefits for other parties. This document highlights key points from a high-level Forum organised and facilitated by the Office of Health Economics and RAND Europe which met in Cambridge on 11th May 2010 to discuss the nature of spillover effects from biomedical and health research and strategies to realise their benefits. The Forum discussed a number of aspects of spillovers and identified the top priorities for policy research that could help bring spillover effects more explicitly into policy decisions.
Enhancing the benefits from biomedical and health research spillovers between public, private and charitable sectors in the UK. Santa Monica, CA: RAND Corporation, 2010. https://www.rand.org/pubs/occasional_papers/OP319.html.
Enhancing the benefits from biomedical and health research spillovers between public, private and charitable sectors in the UK, Santa Monica, Calif.: RAND Corporation, OP-319-OHE, 2010. As of November 16, 2021: https://www.rand.org/pubs/occasional_papers/OP319.html